Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
As real estate is reshaped by AI and affordability pressures, Malte Kramer, CEO and Founder of Luxury Presence, explains how agents adapt, scale, and win.
Global markets hit a turning point as Michael Spence, Nobel Prize–winning economist and Professor Emeritus at Stanford University, assesses risks and growth.
